RENAL FAILURE IS REVERSIBLE AFTER THERAPY WITH BORTEZOMIB IN PATIENTS WITH MULTIPLE MYELOMA

被引：0
|
作者：
Goranova-Marinova, V. [1 ]
Nedeva, A. [2 ]
Nikolov, I. [2 ]
Georgiev, P. [1 ]
Hristova, I. [1 ]
Gigov, I. [2 ]
Raynov, J. [2 ]
Goranov, S. [1 ]
机构：
[1] Univ Hosp Sv Georgi, Clin Hematol, Plovdiv, Bulgaria
[2] Mil Med Acad, Dept Hematol & Oncol, Sofia, Bulgaria
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1508
引用
收藏
页码：602 / 603
页数：2
相关论文
共 50 条
  • [21] Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study
    Chanan-Khan, Asher A.
    Kaufman, Jonathan L.
    Mehta, Jayesh
    Richardson, Paul G.
    Miller, Kena C.
    Lonial, Sagar
    Munshi, Nikhil C.
    Schlossman, Robert
    Tariman, Joseph
    Singhal, Seema
    BLOOD, 2007, 109 (06) : 2604 - 2606
  • [22] Consolidation and maintenance therapy with bortezomib for Vietnamese patients with multiple myeloma after autologous transplantation**
    Vu, Minh Phuong
    Kieu, Thi Van Oanh
    Vu, Hoang
    LEUKEMIA RESEARCH REPORTS, 2023, 19
  • [23] Short Term Renal Outcome of Bortezomib Based Therapy in Patients with Multiple Myeloma Requiring Dialysis
    Pandey, Alok Kumar
    Agarwal, Dhananjai
    Rathore, Vinay
    Sharma, Gaurav Sekhar
    Nowal, Shyam Sunder
    Beniwal, Pankaj
    Jhorawat, Rajesh
    Malhotra, Vinay
    Sharma, Sanjeev
    INDIAN JOURNAL OF NEPHROLOGY, 2020, 30 (03) : 213 - 214
  • [24] Bortezomib Combination Therapy in Multiple Myeloma
    Kapoor, Prashant
    Ramakrishnan, Vijay
    Rajkumar, S. Vincent
    SEMINARS IN HEMATOLOGY, 2012, 49 (03) : 228 - 242
  • [25] Optimizing therapy in bortezomib-exposed patients with multiple myeloma
    Migkou, Magdalini
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Dimopoulos, Meletios Athanasios
    EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (06) : 463 - 469
  • [26] BORTEZOMIB-BASED THERAPY IN FRAIL MULTIPLE MYELOMA PATIENTS
    Antonioli, E.
    Staderini, M.
    Nozzoli, C.
    Bacchiarri, F.
    Barone, F.
    Grieco, P.
    Coltro, G.
    Guarrera, A.
    Messeri, M.
    Bosi, A.
    HAEMATOLOGICA, 2017, 102 : 132 - 132
  • [27] Bortezomib and Vorinostat Therapy as Maintenance Therapy after Autologous Transplant for Multiple Myeloma
    Holmberg, Leona A.
    Green, Damian
    Libby, Edward
    Becker, P. S.
    ACTA HAEMATOLOGICA, 2020, 143 (02) : 146 - 154
  • [28] Thalidomide in patients with multiple myeloma and renal failure
    Fakhouri, F
    Guerraoui, H
    Presne, C
    Peltier, J
    Delarue, R
    Muret, P
    Knebelmann, B
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (01) : 96 - 97
  • [29] Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy
    J R Berenson
    J D Hilger
    O Yellin
    R Dichmann
    D Patel-Donnelly
    R V Boccia
    A Bessudo
    L Stampleman
    D Gravenor
    S Eshaghian
    Y Nassir
    R A Swift
    R A Vescio
    Leukemia, 2014, 28 : 1529 - 1536
  • [30] Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy
    Berenson, J. R.
    Hilger, J. D.
    Yellin, O.
    Dichmann, R.
    Patel-Donnelly, D.
    Boccia, R. V.
    Bessudo, A.
    Stampleman, L.
    Gravenor, D.
    Eshaghian, S.
    Nassir, Y.
    Swift, R. A.
    Vescio, R. A.
    LEUKEMIA, 2014, 28 (07) : 1529 - 1536
12345